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Although both conventional dendritic cells (cDCs)
and plasmacytoid dendritic cells (pDCs) are present
in the gut-associated lymphoid tissues (GALT), the
roles of pDCs in the gut remain largely unknown.
Here we show a critical role for pDCs in T cell-inde-
pendent (TI) IgA production by B cells in the GALT.
When pDCs of the mesenteric lymph nodes (MLNs)
and Peyer’s patches (PPs) (which are representative
GALT) were cultured with naive B cells to induce TI
IgAclass switch recombination (CSR), IgAproduction
was substantially higher than in cocultures of these
cells with cDCs. IgA production was dependent on
APRIL and BAFF production by pDCs. Importantly,
pDC expression of APRIL and BAFF was dependent
on stromal cell-derived type I IFN signaling under
steady-state conditions. Our findings provide insight
into the molecular basis of pDC conditioning to
induce mucosal TI IgA production, which may lead
to improvements in vaccination strategies and treat-
ment for mucosal-related disorders.
INTRODUCTION
In mammals, IgA is the most abundant immunoglobulin isotype
in the body under steady-state conditions. It is synthesized
mainly as a secretory form in gut-associated lymphoid tissues
(GALT) (Cerutti, 2008). Secretory IgA prevents mucosally trans-
mitted pathogens and commensal bacteria from binding to
epithelial cells and neutralizes their toxins to maintain homeo-
stasis at mucosal surfaces. IgA class-switch recombination
(CSR) is induced by both T cell-dependent (TD) and -indepen-
dent (TI) pathways, with the former predominating at Peyer’s
patches (PPs) (Butcher et al., 1982; Casola et al., 2004). The
latter may occur in the lamina propria (LP) (Fagarasan et al.,
2001; He et al., 2007) and isolated lymphoid follicles (ILFs) (Tsuji
et al., 2008). In TD IgA CSR, antigen (Ag)-specific naive B cells
differentiate into IgA+-committed B cells upon stimulation with
CD40L on activated T cells and TGF-b1 expressed by multiplecell types, such as intestinal epithelial cells (IECs), dendritic cells
(DCs), stromal cells (SCs), and T cells, leading to production of
Ag-specific high-affinity IgA, which neutralizes pathogens and
their toxins (Cerutti, 2008). Alternatively, TI IgA CSR is induced
in polyclonal naive B cells by DC- and IEC-derived molecules:
a proliferation-inducing ligand (APRIL) and B cell-activating
factor of the tumor necrosis factor family (BAFF) through their
receptor transmembrane activator and cyclophilin ligand inter-
actor (TACI) and retinoic acid (RA). TI IgA CSR contributes to
production of polyclonal low-affinity IgA, which presumably limit
the adhesion of commensal bacteria to IECs (Mora et al., 2006;
Tezuka et al., 2007; He et al., 2007; Xu et al., 2007; Massacand
et al., 2008). B-1 cells also participate in mucosal TI IgA produc-
tion (Bos et al., 1996).
DCs are composed of two phenotypically and functionally
distinct subpopulations, conventionalDCs (cDCs) andplasmacy-
toid DCs (pDCs), both of which are present in the GALT (Iwasaki,
2007). cDCs have been well characterized by their distributions
in the GALT and their critical functions in the maintenance
of gut homeostasis, immune responses against gut infection,
and inflammatory bowel diseases (Iwasaki, 2007). In contrast,
although pDCs are also found in the GALT, e.g., in the subepithe-
lial dome (SED) and interfollicular regions of the PPs and LP
(Contractor et al., 2007; Wendland et al., 2007), little is known
about their function in the maintenance of gut homeostasis.
In the present study, we found that MLN and PP pDCs rather
than MLN and PP cDCs express high amounts of APRIL and
BAFF and that their induction of TI IgA CSR is APRIL and BAFF
dependent. In addition, type I IFN-producing stromal cells
(SCs) were preferentially present in the MLNs and PPs under
steady-state conditions. Thus, SC-derived type I IFNs are likely
to upregulate the expression of APRIL and BAFF by pDCs,
leading to TI IgA production in the GALT.
RESULTS
T Cell-Independent IgA Production Is Dominant
in the MLNs
IgA CSR takes place in the MLNs, a representative GALT (Bos
et al., 1996; Yamamoto et al., 2000, 2004; Macpherson and
Uhr, 2004; Bergqvist et al., 2006). By using WT and T cell-defi-
cient Tcrb/Tcrd/ mice, we first examined the relative contri-
bution of TD versus TI IgA CSR in the MLNs (Figure 1A). AsImmunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc. 247
AB C
D
E F
Ig
A 
(ng
/m
l)
0
1000
2000
3000
4000
PP MLN PLN
*
Tcrb-/-Tcrd -/-
WT
Tcrb-/-Tcrd -/-
WT
0
0.25
0.5
0.75
1
1.25
Aicda
PP MLNR
el
at
iv
e 
m
R
N
A 
ex
pr
es
sio
n
0
5
10
15
20
- +B cells
Serum
0
0.5
1
1.5
- +
IC
**
Ig
A 
(µg
/m
l)
.
0
0.25
0.5
0.75
1
1.25
0
4
8
12
PP MLN
*
Ig
A+
 
ce
lls
/B
22
0+
 
ce
lls
 (%
)
Tcrb-/-Tcrd -/-
WT
0.00
0.08
SPL
0.00
0.65
MLN
0.06
LP
3.56
IgA
CD
19
B cells
-
+
IgA
3.55 0.49
0.18 0.39
WT Tcrb-/-Tcrd -/-
PP
MLN
B2
20
Gapdh
GT
Tcrb-/-Tcrd-/-WT
CT
Aicda
Figure 1. MLN Is an Inductive Site for T Cell-Independent IgA Production
(A) IgA production by MNCs from PPs, MLNs, and PLNs from WT and Tcrb/Tcrd/ mice cultured for 3 days. Data are representative of four independent
experiments.
(B) MNCs from PPs and MLNs from the indicated mice stained for IgA and B220.
(C) Percentage of IgA+ cells per total B220+ cells in the PP andMLN of WT and Tcrb /Tcrd/mice. Numbers in FACS plots indicate the proportion of the cells.
Each group includes four mice.
(D) Aicda expression in PP andMLN B cells, determined by qPCR (left), and a-germline transcripts (aGT), Aicda, and a-circle transcripts (aCT) expression in MLN
CD19+ B cells, determined by RT-PCR.
(E and F) Naive B cells from the Tcrb/Tcrd/micewere transferred into Il2rg/Rag2/mice, and 2weeks later, MNCs from the indicated organswere stained
for IgA and B220 (E), and the IgA amounts in the sera and intestinal contents (IC) was measured (F).
Numbers in FACS plots indicate the proportion of the cells. Data are representative of three independent experiments with three mice per group. *p < 0.05. Error
bars indicate the SEM.
Immunity
Role of pDCs in Mucosal TI IgA Inductionexpected from previous studies (Butcher et al., 1982; Casola
et al., 2004), the mononuclear cells (MNCs) isolated from
the PPs of Tcrb/Tcrd/ mice produced substantially lower
amounts of IgA than those of WT mice, indicating that the TD
IgA CSR is dominant in the PPs. In contrast, the MNCs from
the MLNs of the Tcrb/Tcrd/ mice produced IgA at similar
titers to those of WTmice, implying that TI IgA production is rela-
tively dominant in the MLNs. Nonmucosal PLN cells failed to
produce IgA in either strain. Indeed, compared with WT mice,
both the number of postswitch IgA+ B cells and the B cell expres-
sion of Aicda, a gene encoding activation-induced cytidine
deaminase (AID), a critical enzyme for CSR, were reduced in
the PP B cells of the Tcrb/Tcrd/ mice, whereas there was
much less effect on the MLN B cells of these mice (Figures248 Immunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc.1B–1D). Consistent with these results, a-germline transcripts
and circle transcripts were detected in MLN B cells (Figures
1D). The MLNs in WT mice contained postswitch IgA+ B cells
that aggregated within germinal centers (GCs) and were scat-
tered in B cell follicles (Figures S1A and S1B available online),
whereas in theMLNs of Tcrb/Tcrd/mice that lack GCs (Tsuji
et al., 2008), all IgA+ B cells were scattered in B cell follicles
(Figures S1C and S1D). In addition, naive B cells, which were iso-
lated from Tcrb/Tcrd/ mice and injected into cytokine
receptor common g chain (Il2rg)/Rag2/ mice, which lack
PPs, ILFs, and most LNs except for MLNs (Cao et al., 1995),
differentiated into a small but substantial number of postswitch
IgA+ B cells in theMLNs but not in the spleen (Figure 1E). Consis-
tent with these results, IgA+ plasma cells in the LP as well as IgA
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Figure 2. MLN pDCs Induce IgA Production in an APRIL- and BAFF-Dependent Manner
(A) IgA level produced by naive B cells cocultured with MLN pDCs, MLN cDCs, or PLN pDCs for 7 days, evaluated by ELISA. Data are representative of four
independent experiments.
(B and D) Tnfsf13, Tnfsf13b (B), and Aldh1a2 (D) expression in MLN cDCs or pDCs, and PLN pDCs, examined by qPCR. Data are representative of three
independent experiments.
(C and F) IgA level produced by naive B cells cocultured with the indicated DC subsets in the presence or absence of TACI- and BCMA-Ig (C) and LE540 (F) for
7 days, evaluated by ELISA. Data are representative of five independent experiments.
(E) MLN cells were incubated with ALDEFLUOR (ALDH) in the presence or absence of DEAB, a competitive inhibitor of ALDH, then stained for CD11c ormPDCA1.
Numbers in FACS plots indicate the proportion of the cells and data are representative of four independent experiments. **p < 0.01; *p < 0.05. Error bars indicate
the SEM.
Immunity
Role of pDCs in Mucosal TI IgA Inductionproduction in the serum and intestinal contents (IC) were
detected in Il2rg/Rag2/ mice that had received the naive B
cells from the Tcrb/Tcrd/ mice (Figures 1E and 1F). These
results indicate that TI IgA production is dominant in the MLNs.
Prominent Role of Mucosal pDCs in TI IgA Induction
Previous studies have shown that DCs of the GALT, possibly
including both cDCs and pDCs, can induce naive or activated
B cells to differentiate into IgA-producing plasma cells in the
absence of T cells in vitro (Mora et al., 2006; Tezuka et al.,
2007; Massacand et al., 2008). However, little is known about
the distinct features of cDCs and pDCs in the induction of TI
IgA CSR. To compare the induction of TI IgA CSR by cDCs and
pDCs, each DC subset was isolated from the MLNs and PPs
(Figures S2A and S2B) and cultured with naive B cells without
additional stimulation. Although both DC subsets from these
tissues induced IgA production from naive B cells, the pDCs
induced substantially higher amounts of IgA production than
the cDCs, which was coincident with the pDC-dependent induc-
tion of a-circle transcripts in B cells (Figure 2A; Figures S2C andS2D). In addition, PLN pDCs induced little IgA (Figure 2A), indi-
cating that pDCs residing in the MLNs and PPs play a pivotal
role in the TI IgA CSR in B cells. Supporting this notion, although
pDCs represent only a minor population (15%–20%) of the total
DC compartment inWTmice, the contribution of theMLNandPP
pDCs to TI IgA production reached 40%–45% of the total
induced by MLN and PP DCs (Figures S2E and S2F).
Mucosal DCs are a main producer of APRIL and BAFF, critical
cytokines for TI IgA CSR (Massacand et al., 2008). BecauseMLN
and PP pDCs were the prominent inducer of TI IgA production,
we asked whether this unique and distinct property of pDCs
was due to their differential production of APRIL and BAFF, via
quantitative PCR (qPCR). Importantly, the freshly isolated MLN
and PP pDCs expressed Tnfsf13 and Tnfsf13b, genes encoding
APRIL and BAFF, respectively, at substantially higher amounts
than theMLNandPP cDCsor PLNpDCs (Figure 2B; Figure S2G),
and the results correlated well with the ability of each DC subset
to induce TI IgA production (Figure 2A; Figure S2C). Interestingly,
the IgA titers induced by pDCs were comparable to those
induced by around 400 ng/ml BAFF or APRIL (Figure S2H).Immunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc. 249
Immunity
Role of pDCs in Mucosal TI IgA InductionTo examine whether the MLN and PP pDC-derived APRIL and
BAFF were responsible for the TI IgA induction, naive B cells
were cocultured with the pDCs in the presence of BCMA-,
TACI-, and BAFFR-Ig, which block the binding of APRIL and
BAFF to their corresponding receptors. Notably, although
BAFFR was originally reported to be a BAFF-specific receptor
(Thompson et al., 2001), a comprehensive survey of ligand-
receptor interactions revealed that mouse APRIL binds substan-
tially to mouse BAFFR, although with weaker affinity than to
mouse TACI or BCMA (Bossen et al., 2006). The MLN and PP
pDC-induced IgA production was markedly lower in the pres-
ence of BCMA-, TACI-, and BAFFR-Ig compared with control
Ig, suggesting that the effects of BCMA-, TACI-, and BAFFR-Ig
are specific and that the IgA-inducing capacity of MLN and PP
pDCs is indeed due to their prominent expression of APRIL
and BAFF (Figure 2C; Figures S2I and S2L). Compared with
that of MLN pDCs, the PLN pDC-induced IgA production was
much lower and was unaffected by BCMA- and TACI-Ig (Fig-
ure 2C). Consistent with these results, some pDCs were in close
contact with B cells, including IgA+ B cells, in B cell follicles of the
MLNs of WT and Tcrb/Tcrd/ mice (Figures S1A–S1D).
Involvement of Other Factors in pDC-Mediated
TI IgA Induction
We further tested whether TGF-b, IL-6, or IL-10 was required for
the pDC-mediated TI IgA production, because these cytokines
are known to be important in the APRIL and BAFF-dependent
IgA production in human and mouse (Cerutti, 2008; Tsuji et al.,
2008). Culturing naive B cells with MLN and PP pDCs in the pres-
ence or absence of control Ab or with a neutralizing Ab against
TGF-b, IL-6, or IL-10 revealed that IgA production was unaf-
fected by the anti-TGF-b (Figures S2J and S2M) and was
partially reduced by anti-IL-6 or anti-IL-10 (Figures S2K and
S2N), suggesting that IL-6 and IL-10, but not TGF-b, are involved
in the pDC-mediated IgA production, at least in this experimental
setting. In line with the results, MLN and/or PP pDCs produced
both IL-6 and IL-10 without stimulation, whereas they expressed
Tgfb1 and Itgb8, a component of avb8 that mediates the conver-
sion of latent TGF-b to active one, at substantially lower levels
compared with cDCs (Figures S2O and S2P).
In the GALT, vitamin A (also known as retinol), which is
obtained from the diet, is oxidized to retinal by alcohol dehydro-
genases (ADH) and then to retinoic acid (RA) by aldehyde dehy-
drogenase 1A (ALDH1A) (Iwata et al., 2004;Mora et al., 2008). RA
from MLN DCs functions synergistically with IL-6 and IL-5 to
induce IgA production (Mora et al., 2006). To determine whether
pDCs contribute substantially to RA production, we compared
mRNA expression and enzymatic activity of ALDH1A2, an
isoform of ALDH, between the cDCs and pDCs in MLNs. As
reported previously, the MLN cDCs expressed Aldh1a2 and
showed ALDH activity at substantial levels (Figures 2D and 2E;
Coombes et al., 2007; Yokota et al., 2009). In contrast, the
MLN and PLN pDCs expressed little Aldh1a2, if any, and ex-
hibited low ALDH activity (Figures 2D and 2E). Consistent with
these results, the MLN cDC-induced IgA production was signif-
icantly inhibited, whereas the MLN pDC-induced IgA production
was minimally affected by the addition of LE540, an RA-receptor
antagonist (Figure 2F). These results indicated that the MLN
pDC-induced IgA production is largely dependent on APRIL250 Immunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc.and BAFF and independent of RA. In contrast, MLN cDC-medi-
ated IgA production is significantly dependent on RA, although
some contribution of APRIL and BAFF cannot be completely
excluded.
Unique Crosstalk between pDCs and B Cells Resulting
in IgA Production
APRIL and BAFF can exist in soluble or membrane-bound forms
(Mackay et al., 2003). To examine whether soluble and/or
membrane-bound APRIL and BAFF were critical for the MLN
pDC-induced TI IgA production, we cultured MLN DC subsets
and naive B cells in a transwell system in which the DCs were
unable to contact the B cells, thereby restricting their access
to all but diffusible factors, and measured the IgA production.
In this system, MLN cDCs induced IgA to a similar degree to
that achieved in conventional culture (Figure 3A). In contrast,
the MLN pDC-mediated IgA production was substantially in-
hibited by blocking the cell-to-cell interaction via the transwell
system (Figure 3A). Irradiation blocks synthesis of soluble
proteins but not expression of membrane-bound molecules.
Consistent with these results via a transwell system, irradiated
MLN pDCs were able to induce IgA to a similar degree as
untreated MLN pDCs and failed to induce IgA in the presence
of BCMA- and TACI-Ig (Figure 3B), suggesting that membrane-
bound APRIL and BAFF on MLN pDCs are biologically active
and responsible for TI IgA production. In contrast, irradiated
MLN cDCs failed to induce TI IgA production. Supporting this
notion, membrane-bound APRIL and BAFF were indeed detect-
able on some MLN and PP pDCs but not on MLN cDCs, in the
absence or presence of CpG stimulation, an efficient activator
of DCs (Figure 3C; Figure S3A). In this context, the pDCs did
not express BCMA, TACI, or BAFFR, excluding the possibility
that soluble APRIL and BAFF act by binding to their receptors
expressed on pDCs (Figure S3B).
In addition, the expression of furin convertase, an enzyme that
cleaves the membrane-bound form of APRIL and BAFF to
release them as soluble ligands (Mackay et al., 2003), was
substantially lower in MLN pDCs than in MLN cDCs (Figure 3D).
Interestingly, upon CpG stimulation, the expression of furin was
enhanced in cDCs but not in pDCs (Figure S3C), implying that
APRIL and BAFF largely remained membrane-bound to pDCs,
even after their activation. Consistent with these results, CpG-
stimulated MLN pDCs remained unable to secrete detectable
amounts of soluble BAFF (data not shown), and MLN pDC-
and cDC-induced IgA production was further enhanced in the
presence of a furin inhibitor (Figure S3D). These results collec-
tively indicated that MLN pDCs uniquely express membrane-
bound APRIL and BAFF for IgA induction and thus require
some cell-to-cell contact with B cells to carry out this function.
pDC Expression of APRIL and BAFF Is Dependent
on Type I IFN Signaling
Given the important and unique role of MLN and PP pDCs in TI
IgA induction, and the requirement for high amounts of Tnfsf13
and Tnfsf13b expression, we investigated how Tnfsf13 and
Tnfsf13b expression is regulated in these cells. Previous work
had established that type I IFNs regulate Ig production (Le Bon
et al., 2001; Jego et al., 2003) and are potent inducers of APRIL
and BAFF in human DCs (Litinskiy et al., 2002), and we therefore
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Figure 3. Unique Crosstalk between pDCs
and B Cells Leading to IgA Production
(A and B) IgA level produced by naive B cells
cultured with untreated (A) or irradiated (B) DC
subsets isolated fromMLNs in a Transwell system
or in conventional culture for 7 days, and evalu-
ated by ELISA. Data are representative of three
or four independent experiments.
(C) The expression of membrane-bound APRIL
and BAFF on untreated and CpG-stimulated
MLN pDCs. Solid line, APRIL and BAFF staining;
dashed line, isotype control staining. Numbers in
histograms indicate percentages of the cells.
(D) MLN cDCs and pDCs were examined for furin
expression by qPCR. Data are representative of
two to four independent experiments.
*p < 0.05. Error bars indicate the SEM.
Immunity
Role of pDCs in Mucosal TI IgA Inductionhypothesized that type I IFNs play a critical role in TI IgA synthesis
by upregulating the pDC expression of Tnfsf13 and Tnfsf13b. To
test this idea, we cultured PLN pDCs, which express neither
Tnfsf13 nor Tnfsf13b, in the presence of IFN-a. Notably, the
PLN pDCs acquired the expression of Tnfsf13 and Tnfsf13b at
substantial amounts (Figure S4A), implying that the high amounts
of these molecules in MLN pDCs are due to physiologically
produced type I IFNs in the GALT. In fact, under steady-state
and specific-pathogen-free (SPF) conditions, type I IFNs are
produced constitutively, although at low amounts, by a variety
of cell types and tissues (Taniguchi and Takaoka, 2001).
To further study the role of type I IFNs in TI IgA CSR, we quanti-
fied the IgA levels in the sera and fecal pellets of mice deficient for
IFNAR1, a component of type I IFN-receptor, or IFN-b, and found
that these IgA titerswere substantially lower than inwild-typemice
(Figure 4A; Figure S4B). However, upon stimulation with APRIL or
BAFF in vitro, naive Ifnar1/ B cells produced IgA to a degreeImmunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc. 251,
,
)
,similar to naiveWTBcells, suggesting that
Ifnar1/ B cells are competent for TI IgA
synthesis (Figure 4B). Therefore, we inves-
tigated whether Ifnar1/ pDCs could
induce TI IgA production by culturing
either WT or Ifnar1/ MLN pDCs with
naive WT B cells. We found that the WT
MLN pDC-induced IgA production was
significantly reduced in the presence of
BCMA- and TACI-Ig (Figure 4C), confirm-
ing the involvement of pDC-derived APRIL
and BAFF in TI IgA production. Further-
more, the Ifnar1/ MLN pDC-induced
IgA production was also substantially
reduced, to the amount of the WT MLN
pDCs cultured with BCMA- and TACI-Ig,
which correlated well with the impaired
expression of Tnfsf13 and Tnfsf13b in
these cells (Figures 4C and 4D). Finally,
the Ifnar1/ MLN pDC-induced IgA
production was restored by the addition
of APRIL or BAFF (Figure 4C).
We previously showed that IgA
production is severely impaired inNos2/ mice and that nitric oxide (NO) derived from naturally
occurring TNF, iNOS (double)-producing DCs (Tip-DCs) plays
a critical role in expression of Tnfsf13 and Tnfsf13b in GALT
DCs (Tezuka et al., 2007). As expected, the Nos2/ pDCs iso-
lated from MLNs showed a reduced capacity to induce TI IgA
with impaired Tnfsf13 and Tnfsf13b expression (Figures S4C
and S4D), and the expression of Nos2was significantly impaired
in Ifnar1/CD11c+ cells in the MLNs (Figure S4E), implying that
under steady-state conditions, type I IFNs induce Tip-DCs, and
their product NO acts on pDCs and, together with type I IFN
signaling, effectively enhances BAFF-APRIL expression by
pDCs. Supporting this hypothesis, iNOS-expressing cells in the
GALT are Tip-DCs and do not include pDCs (B220+CD11cint
(Tezuka et al., 2007) in vivo. An impaired expression of iNOS is
also evident in Ifnar1/ macrophages (Vadiveloo et al., 2000).
To confirm the critical role of pDCs in mucosal TI IgA produc-
tion in vivo, we carried out the adoptive transfer of 13 106 pDCs
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Figure 4. Impaired APRIL and BAFF Expres-
sion and TI IgA Induction by pDCs Lacking
the Type I IFN Receptor
(A) IgA level in the serum and fecal pellets (FP) of
Ifnar1/ mice. Representative data from two
independent experimentswith fourmice per group
are shown.
(B) IgA level produced by naive B cells from WT
and Ifnar1/ mice stimulated with APRIL or
BAFF for 7 days.
(C) IgA level produced by naive B cells cocultured
with MLN pDCs of WT and Ifnar1/ mice in the
presence or absence of APRIL or BAFF for
7 days. ND, not determined. Data are representa-
tive of four independent experiments.
(D) Tnfsf13 and Tnfsf13b expressed by WT and
Ifnar1/ pDCs, determined by qPCR. Data are
representative of three independent experiments.
(E and F) PLN pDCs of B6.SJL mice (CD45.1+)
were transferred into Ifnar1/ hosts (CD45.2+).
The number of CD45.1+ cells in the MLN/LP
16 hr after the transfer (E) and the IgA level in the
serum and IC (F) 2 weeks after the transfer.
Numbers in FACS plots indicate the proportion of
the cells, and representative data from two inde-
pendent experiments with four mice per group
are shown. IgA levels were determined by ELISA.
*p < 0.05. Error bars indicate the SEM.
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transferred PLN pDCs, which express CCR9, a representative
gut-homing receptor, migrated into both the MLNs and intestinal
LP to some extent and significantly restored IgA production in
the sera and intestinal contents (Figures 4E and 4F). Taken
together, these results indicate that type I IFN signaling is critical
for mucosal pDC expression of APRIL and BAFF.
Identification of Type I IFN-Producing Cells and
Evidence of Type I IFN Signature on Mucosal pDCs
Our results implied that physiological type I IFN-producing cells
are present in theMLNs ofWTmice under SPF conditions. In this
context, we found that, in the MLNs, numerous CD45ER-TR7+
stromal cells (SCs) expressed IFN-a and IFN-b, which were
located at or near the edge of the cytoplasm (Figures 5A and
5B for IFN-a, Figures 5D and 5E for IFN-b). In contrast, few
SCs in the PLNs expressed type I IFNs (Figures S5A and S5B
for IFN-a, Figures S5C and S5D for IFN-b). Importantly, the SC
expression of type I IFNs was impaired in germ-free and
Myd88/Trif/ mice (Figures 5C and 5F; Figures S5E and
S5F), suggesting that the TLR-dependent recognition of
commensal bacteria is required for the SC production of type I
IFNs, leading to the activation of pDCs tomake APRIL and BAFF.
We next investigated the expression of various genes in the
type I IFN pathway and obtained supporting evidence of the252 Immunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc.influence of type I IFNs on pDCs in the
MLNs. First, mRNA expression of both
IFN-a and IFN-b in the MLN and PP SCs
was higher than in the MLN pDCs and
splenic SCs (Figure 5G; Figures S5G
and S5H). Second, expression of themRNA for protein kinase receptor (PKR), a type I IFN-inducible
gene essential for the expression of APRIL and BAFF (Harden-
berg et al., 2007), was higher in the MLN pDCs of WT mice
than in the MLN cDCs of WT mice or the MLN pDCs of Ifnar1/
mice (Figure 5H), suggesting that MLN pDCs constitutively
receive type I IFN signaling under steady-state and SPF condi-
tions. Importantly, the expression level of type I IFN receptor in
pDCswas significantly higher than that in cDCs (Figure 5I), which
was likely to lead to their different responses to type I IFNs in the
MLNs. In addition, both pDCs and cDCs were in close contact
with SCs in the extrafollicular area beside the B cell follicles in
the MLNs (Figures S5I–S5L), implying that after pDCs are condi-
tioned at this site, they migrate into the B cell follicles to induce TI
IgA CSR. Supporting this scenario, the colocalization of naive B
cells and pDCs was detected predominantly in the B cell follicle
(Figures S1A–S1D), whereas little colocalization of naive B cells
and pDCs with SCs was observed (data not shown). Third,
type I IFNs mediate the upregulation of CD69 expression on
pDCs during viral infections and even under steady-state condi-
tions (Gao et al., 2009). We also found that WT MLN pDCs
expressed CD69 at a substantially higher level than WT PLN
pDCs, and Ifnar1/ pDCs expressed little CD69 (Figure 5J),
suggesting the preferential expression of type I IFNs in the
MLNs. Collectively, these results suggest that, under steady-
state SPF conditions, type I IFNs are produced constitutively,
Immunity
Role of pDCs in Mucosal TI IgA Inductionalbeit at low levels, by MLN SCs, and that they act on pDCs to
induce the expression of APRIL and BAFF in the MLNs.
DISCUSSION
PPs are a major inductive site for TD IgA CSR. In contrast, TI IgA
CSR is preferentially induced in ILFs where few T cells are found
(Tsuji et al., 2008). IgA CSR is also induced in the MLNs (Bos
et al., 1996; Macpherson and Uhr, 2004; Bergqvist et al.,
2006), although the frequency of IgA CSR in the MLNs is lower
than in PPs. Furthermore, antigen-specific IgA CSR takes place
in the MLNs of PP-null mice (Yamamoto et al., 2000). Although
Ltb/ mice lack PPs and ILFs, most individuals have MLNs,
albeit smaller than normal, and some secreted IgA is produced
(Alimzhanov et al., 1997; Fletcher et al., 2006). Given this back-
ground, we examined the contribution of TD and TI IgA induction
and the role of DC subsets in IgA induction in the MLNs, and we
noted that TI IgA CSR is relatively prominent in this tissue.
Among the DC subsets, the pDCs played a pivotal role in the
TI IgA CSR by their predominant expression of APRIL and
BAFF.Moreover, the SC-derived type I IFNs induced the expres-
sion of APRIL and BAFF by pDCs in the MLNs under steady-
state conditions. Notably, in the MLNs, pDCs were located in
B cell follicles as well as extrafollicular area where SCs are
present, implying that pDCs are conditioned by SCs in the extra-
follicular area and subsequently migrate into the B cell follicles to
induce TI IgA CSR.
TGF-b is essential for T cell (CD40L)-dependent IgA produc-
tion (Cerutti, 2008). Regarding the TI IgA production by mouse
B cells, SC-mediated TI IgA production requires TGF-b, APRIL,
and BAFF (Tsuji et al., 2008), whereas APRIL and BAFF can
induce IgA CSR without TGF-b in naive B cells (Castigli et al.,
2005), implying that the requirement of TGF-b for TI IgA produc-
tion depends on the cell type and experimental system used.
In this context, GALT pDCs might express an unidentified
molecule(s) in addition to membrane-bound APRIL and BAFF,
which, instead of TGF-b, mediates Ca transcription. The mech-
anisms of Ca transcription remain to be clarified in future studies.
Unlike the ILFs, MLNs contain distinct T cell zones populated
by a large number of T cells. Nevertheless, TI IgA CSR is prefer-
entially induced in the MLNs. The MLNs are also the key site for
tolerance induction to food proteins and commensal bacteria
(Macpherson and Smith, 2006). DCs transport food and
commensal antigens from the intestinal surface into the MLNs
through the afferent lymphatics, present the antigens to T cells,
and induce T cell tolerization, which may explain why the
MLNs play only a minor role in TD IgA CSR.
Type I IFNs are induced to high amounts by infectious stimuli,
including viral and bacterial infections (Asselin-Paturel et al.,
2001). Under basal conditions, in the absence of infection, as
in mice kept under SPF conditions, type I IFNs are produced
constitutively at low levels by multiple cell types, including
DCs, macrophages, Paneth cells (defensin- and lysozyme-
secreting intestinal epithelial cells), and thymic epithelial cells
(Taniguchi and Takaoka, 2001; Montoya et al., 2002; Munakata
et al., 2008; Lienenklaus et al., 2009). The functional importance
of this basal expression of type I IFN production is demonstrated
by the finding that Ifnar1/ mice kept under SPF conditions
spontaneously develop osteoporosis caused by a lack of phys-iological type I IFN signaling, which limits osteoclast differentia-
tion (Takayanagi et al., 2002).
In line with these results, we found that type I IFNs in the MLNs
are exclusively expressed by the stromal cells in theMLNs under
steady-state SPF conditions and that the TLR-dependent recog-
nition of commensal bacteria is required for this process.
Although large amounts of type I IFNs are produced by pDCs
in response to viral infections, we did not detect the production
of type I IFNs in the pDCs of the MLNs under steady-state condi-
tions. Related to this, pDCs of the PPs fail to produce type I IFNs
upon CpG stimulation (Contractor et al., 2007), implying the
presence of regulatory mechanisms in the GALT, e.g., prosta-
glandin E2, IL-10, and TGF-b signaling, that prevent harmful
immune responses and maintain tolerogenic conditions.
Accumulating evidence suggests that SCs function not only to
provide migratory guidance for immune cells (Baje´noff et al.,
2006) but also as immune regulatory cells in the GALT. For
example, the SCs of theMLNs express ALDH enzymes to induce
gut-homing tropism by T cells (Hammerschmidt et al., 2008), and
the SCs of the LPs produce TGF-b to induce IgACSR (Fagarasan
et al., 2001). In addition, the formation of ILFs requires interac-
tions between the lymphoid-tissue inducer cells and SCs (Tsuji
et al., 2008). Given that SC-derived type I IFNs act on pDCs to
induce APRIL and BAFF, it appears that SCs play a critical role
in the construction and maintenance of immune homeostasis
in the GALT.
Here we showed that, under steady-state conditions, type I
IFNs are critical for the induction of APRIL and BAFF in pDCs
but not cDCs, and pDCs uniquely express a membrane-bound
form of APRIL and BAFF, raising a couple of questions. First,
regarding the critical function of SC-derived type I IFNs in APRIL
and BAFF induction in the GALT, why do only pDCs, but not
cDCs, express these molecules at high amounts? Related to
this, we unexpectedly found that type I IFNR, i.e., IFNAR1, is ex-
pressed predominantly on pDCs but minimally on cDCs, indi-
cating that pDCs but not cDCs are capable of a potent response
to the SC-derived type I IFNs under steady-state conditions.
Supporting our findings, the pDCs of the MLNs express
high levels of PKR and CD69, type I IFN-inducible genes.
Second, is there any functional difference between soluble and
membrane-bound APRIL and BAFF? In this context, effective
signaling via TACI, a critical receptor for APRIL- and BAFF-medi-
ating IgA CSR, requiresmultimerization of BAFF, heparan sulfate
proteoglycans (HSPGs) as a platform for APRIL, or membrane-
bound ligands, but not soluble ligands (Mackay and Schneider,
2009). In addition, membrane-bound IL-15 is more potent, in
terms of induction of T cell proliferation, than its soluble form
(Musso et al., 1999). Under the background, we speculate that,
compared with soluble APRIL and BAFF, which are randomly
diffused and have limited chance to display their function,
membrane-bound APRIL and BAFF firmly bind, even with rela-
tively low doses, their corresponding receptors on B cells, effec-
tively inducing IgA CSR in B cells.
Under steady-state SPF conditions, a variety of cytokines
condition immunecells tomaintaingut homeostasis. For example,
IECs express thymic stromal lymphopoietin (TSLP) to limit the
production of proinflammatory cytokines, including DC-derived
IL-12 (Zaph et al., 2007; Rimoldi et al., 2005). Granulocyte-macro-
phage colony-stimulating factor (GM-CSF) produced by MLNImmunity 34, 247–257, February 25, 2011 ª2011 Elsevier Inc. 253
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Figure 5. Identification of Type I IFN-Producing Cells and Type I IFN Signature in Mucosal pDCs
(A–F) Frozen sections of MLNs from WT mice (A, B, D, E) and germ-free mice (C, F) fixed and stained for IFN-a or IFN-b (green) and ER-TR7 or CD45.2 (red).
Original magnification 3200.
(G and H) Ifna and Ifnb expression in stromal cells (SCs) (G) and Pkr expression in MLN DCs (H) determined by qPCR.
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Role of pDCs in Mucosal TI IgA Inductionmacrophages conditions cDCs to express ALDH1A2, an enzyme
involved in generating RA (Yokota et al., 2009) and critical for the
imprinting of gut-homing specificity on lymphocytes and the
differentiation of Foxp3+ iTreg cells. Our data indicated that type
I IFNs derived from MLN SCs condition pDCs to express APRIL
and BAFF once peripheral pDCs have migrated into the GALT.
Given that both APRIL and BAFF are important for B cell matura-
tion and survival and that their overproduction is associated with
cancer andautoimmunity (MackayandSchneider, 2009), our find-
ings suggest a possible molecular basis for the control of gut
homeostasis and related disorders.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6), B6.Rag2/, B6.Ifnar1/, and B6.germ-free mice were ob-
tained from Japan CLEA, Central Laboratories for Experimental Animals,
B&K Universal, and Sankyo Labo Service, respectively. B6.Tcrb/Tcrd/,
B6.Ifnb/, and B6.Myd88/Trif/ mice have been described (Nishiyama
et al., 2002; Takaoka et al., 2000; Atarashi et al., 2008). All mice were main-
tained in our SPF animal facility with the Micro-VENT system (Allentown
Caging Equipment Company), and all animal experiments were done with
the approval of the Institutional Animal Care Committee of the Tokyo Medical
and Dental University.
Cell Preparation
PPs collected from small intestines were shaken for 45 min at 37C in PBS
containing 2 mM EDTA to remove epithelial cells. Collagenase (type IV,
Sigma)-digested PP, MLN, and PLN (axillary, brachial, and inguinal LNs) cells
were applied to a discontinuous 40% and 70% Percoll density gradient (GE
Health Care), and the cells at the interface were used as MNCs. To prepare
naive B cells, PP cells were labeled with JF05-1C2.4.1 MicroBeads (anti-
mPDCA-1, Miltenyi Biotec) and Biotin-281-2 (anti-CD138, BD Bioscience) fol-
lowed by anti-Biotin MicroBeads (Miltenyi Biotec). The negative fraction was
labeled with PE-11-26c (anti-IgD, eBioscience) and subsequently with anti-
PEMicroBeads (Miltenyi Biotec). IgD+ B cells were isolated with an AutoMACS
Pro Separator (Miltenyi Biotec) and used as naive B cells (>97% IgD+). To
prepare cDCs, cells from collagenase-digested MLNs, PPs, and PLNs (axil-
lary, brachial, and inguinal LNs) were treated with FcR blocking reagent (Milte-
nyi Biotec), which blocks the nonspecific binding of Abs to FcR. The cells were
labeled with FITC-145-2C11 (anti-CD33), FITC-eBio1D3 (anti-CD19), FITC-
C10-3 (anti-IgA), FITC-II/41 (anti-IgM), PE-281-2 (anti-CD138), FITC-RA3-
6B2 (anti-B220), FITC-1A8 (anti-Ly6G), FITC-DX5 (anti-DX5), PE-TER119
(anti-TER119), mPDCA1 MicroBeads, and subsequently with anti-FITC Mi-
croBeads and anti-PE MicroBeads. The negative fraction was labeled with
N418-MicroBeads (CD11c) and isolated with the AutoMACS Pro. The positive
fraction was used as cDCs (>95%CD11chiI-A+mPDCA1). pDCswere purified
with the pDC isolation kit II (Miltenyi Biotec) with Biotin-281-2 (anti-CD138).
The negative fraction was labeled with N418-MicroBeads (anti-CD11c) and
sorted with the AutoMACS Pro (>95% CD11cintB220+mPDCA1+).
Cell Culture and Measurement of Immunoglobulins and Cytokines
To evaluate TI IgA production, naive B cells (23 105) were either directly stim-
ulated with APRIL or BAFF (50–500 ng/ml, R&D Systems) or cocultured with
cDCs (0.5–23 105) or pDCs (0.5–23 105) in the presence or absence of APRIL
(100 ng/ml) or BAFF (100 ng/ml) and TACI-Ig, BCMA-Ig, BAFFR-Ig, control-Ig
(human IgG1-Ig) (5 mg/ml each, R&D Systems), LE540 (1 mM, Wako), anti-IL-6
(MP5-20F3), anti-IL-10 (JES5-2A5), rat IgG1 isotype control (10 mg/ml each, Bi-
oLegend), anti-TGF-b1, b2, b3 (25 mg/ml, 1D11, R&D systems), mouse IgG1
isotype control (25 mg/ml, BioLegend), and decanoyl-Arg-Val-Lys-Arg-chloro-(I and J) Expression of IFNAR1 (I) and CD69 (J) on cDCs or pDCs from MLNs or
control staining. Numbers in histograms indicate mean fluorescence intensity (M
Data are representative of three independent experiments. *p < 0.05. Error barsmethylketone (CMK, 50 mM, Alexis) for 7 days. To block cell-to-cell contact, the
same numbers of B cells and DCs were cultured in the separate wells of
a transwell device (Corning). In some experiments, MLN cDCs and pDCs
that had been irradiated at 25 Gy were cocultured with naive B cells for
7 days. The level of IgA in the culture supernatants was measured by ELISA
as described previously (Nishiyama et al., 2002; Tezuka et al., 2007). To
examine the effect of type I IFNs on the expression of APRIL and BAFF, PLN
pDCs were stimulated with recombinant mouse IFN-a (100 U/ml, RDI) for
18 hr. To determine membrane-bound forms of APRIL and BAFF, MLN cells
were cultured with or without CpG (2 mM, ODN1668 [50-TCCATGACGTTCCTG
ATGCT-30], Hokkaido System Science) for 16 hr. The levels of IL-6 and IL-10 in
2-day culture supernatants of DC subsets were measured by ELISA (BioLe-
gend and eBioscience, respectively).
Adoptive Transfer
To examine the trafficking and IgA induction ability of pDCs, pDCs (1 3 106)
purified from the MLN and PLN of WT mice (CD45.1+) were intravenously
transferred into Ifnar1/ hosts (CD45.2+). Sixteen hours after the transfer,
MLN and LP cells isolated from the hosts were stained with FITC-104 (anti-
CD45.2) and PE-A20 (anti-CD45.1) and analyzed on a FACSCalibur with the
CELLQuest program (BD Bioscience). Two weeks after the transfer, the IgA
levels of the serum and intestinal contents (IC) were determined by ELISA.
To examine whether the MLNs were the site of IgA CSR, splenic naive B
cells (1 3 107) from the Tcrb/Tcrd/ mice were transferred into BALB/c
Il2rg/Rag2/ hosts. Three weeks after the transfer, LP cells isolated from
the hosts were stained with FITC-C10-3 (anti-IgA) or PE-mA-6E1 (anti-IgA)
and FITC- or PE-eBio1D3 (anti-CD19), and the level of serum IgA was deter-
mined by ELISA.
Flow Cytometric Analysis
Cells were pretreated with FcR blocking reagent (Miltenyi Biotec) and/or
normal mouse serum and then stained with the following mAbs: APC-N418
(anti-CD11c), PE-JF05-1C2.4.1 (anti-mPDCA1), FITC-RA3-B2 (anti-B220),
PE-A3D8 (anti-APRIL), PE-121808 (anti-BAFF), PE-MER1-5A3 (anti-IFNAR1),
Biotin-H1.2F3 (anti-CD69), PE-8F10 (anti-TACI), FITC-161616 (anti-BCMA),
PE-7H22-E16 (anti-BAFF-R), PE-rat IgG2a isotype control, PE-mouse IgG1
isotype control, PE-hamster IgG isotype control, or Biotin-hamster IgG isotype
control. To examine the ALDH activity, cells were stained with an ALDEFLUOR
staining kit (StemCell Technologies) with or without the ALDH inhibitor diethy-
laminobenzaldehyde (DEAB, 100 mM, Sigma Aldrich) as described previously
(Yokota et al., 2009).
PCR
Total RNA was extracted from isolated DCs with the RNeasy Mini Kit
(QIAGEN). The preparation and amplification of cDNA were performed with
RT-PCR high and ReverTra Ace qPCR RT Kit (Toyobo). Specific primer pairs
for RT-PCR were as follows: Aicda sense (50-ATATGGACAGCCTTCTGATGA
AGC-30) and Aicda antisense (50-TCAAAATCCCAACATACGAAATGC-30); aGT
sense (IaF, 50- CCAGGCATGGTTGAGATAGAGATAG-30 ) and aGT antisense
(CaR,50-GAGCTGGTGGGAGTGTCAGTG-30);aCTsense (IaF,50-CCAGGCATG
GTTGAGATAGAGATAG-30) and aCT antisense (CmR, 50-AATGGTGCTGGGC
AGGAAGT-30); and Gapdh sense (50-ACCACAGTCCATGCCATCAC-30) and
Gapdh antisense (50-TCCACCACCCTGTTGCTGTA-30). Specific primers for
nested PCR (for aCT) were as follows: sense (50-ACCCTGGATGACTTCAG
TGT-30) and antisense (50-CATCTGGACTCCTCTGCTCA-30). Real-time PCR
analysis was performedwith a LightCycler 480 (Roche) tomeasure SYBR green
I (Roche) incorporation. Specific primer pairs (Hokkaido System Science Co)
used for real-time PCR were as follows: Aicda sense (50-AACCCAATTTTCAG
ATCGCG-30) and Aicda antisense (50-AGCGGTTCCTGGCTATGATAAC-30);
Tnfsf13 sense (50-TCACAATGGGTCAGGTGGTATC-30) and Tnfsf13 antisense
(50-TGTAAATGAAAGACACCTGCACTGT-30); Tnfsf13b sense (50-TGCTATGGG
TCATGTCATCCA-30) and Tnfsf13b antisense (50-GGCAGTGTTTTGGGCAPLNs (inguinal LNs). Solid line, IFNAR1 or CD69 staining; dashed line, isotype
FI) (J) and fold-change of MFI (IFNAR1 staining/isotype control staining) (I).
indicate the SEM.
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Role of pDCs in Mucosal TI IgA InductionTATTC-30); Furin sense (50-CAGAAGCATGGCTTCCACAAC-30) and Furin anti-
sense (50-TGTCACTGCTCTGTGCCAGAA-30); Aldh1a2 sense (50-GACTTGTAG
CAGCTGTCTTCACT-30 ) and Aldh1a2 antisense (50-TCACCCATTTCTCTCC
CATTTCC-30); Ifna (all genes) sense (50-TCCTGGCGGTGATGAGCTA-30) and
Ifna (all genes) antisense (50-AGTCTGAGGCAGGTCACATCCT-30); Ifnb sense
(50-CCACCACAGCCCTCTCCATCAACTAT-30) and Ifnb antisense (50-CAAGTG
GAGAGCAGTTGAGGACATC-30); Tgfb1 sense (50-GCAACATGTGGAACTCT
ACCAGA-30) and Tgfb1 antisense (50-GACGTCAAAAGACAGCCACTCA-30);
Itgb8 sense (50-CATTCTTGATCGGGTTGCTT-30) and Itgb8 antisense (50-CA
GGCTTTTCTCGTCGGTAG-30); Nos2 sense (50-CTGCCTCATGCCATTGAGT
T-30) and Nos2 antisense (50-TGAGCTGGTAGGTTCCTGTTG-30); and Gapdh
sense (50-TGTGTCCGTCGTGGATCTGA-30) and Gapdh antisense (50-CCTG
CTTCACCACCTTCTTGA-30). The relative expression levels of the mRNA were
normalized to the GapdhmRNA level in each sample.
Immunohistochemical Analysis
LNs and PPs were embedded in Tissue Tek OCT compound and then frozen in
liquid nitrogen. Frozen tissue sections (6 mm) were prepared with a cryostat
(Leica), mounted on microslides, and fixed in methanol. To detect pDCs, the
frozen sections were blocked with Block Ace (Yukijirushi) containing FcR
blocking reagent (Miltenyi Biotec) with or without 5% normal goat or donkey
serum, and then stained with Alexa Fluor 488-N418 (anti-CD11c), Alexa Fluor
488-1D3 (anti-CD19) (Biolegend), FITC-anti-IgA (goat polyclonal, Cappel),
PE-ER-TR7 (Santa Cruz) or PE-11-26c (anti-IgD), and Alexa Fluor 647-927
(anti-PDCA1, Biolegend). To detect IFN-a+ and IFN-b+ cells, the frozen
sections were blocked with Block Ace containing 5% normal donkey serum
and Avidin D/biotin solutions (Vector Laboratories, Burlingame, CA) and
stained with anti-mouse IFN-a or anti-mouse IFN-b (RMMA-1 and RMMB-1,
respectively; PBL Biomedical Laboratories), followed by staining with biotiny-
lated anti-rat IgG (eBioscience). IFN-a+ and IFN-b+ cells were visualized with
avidin-conjugated FITC and PE-104 (anti-CD45) (both from eBioscience) or
PE-ER-TR7. Stained sections were analyzed by fluorescence microscopy
(Leica) and confocal microscopy (Olympus).
Statistical Analysis
The statistical significance of the obtained values was evaluated by Student’s
t test. A p value < 0.05 was considered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.immuni.2011.02.002.
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